Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 1290 
IMAGES
Year : 2006  |  Volume : 12  |  Issue : 1  |  Page : 38

Mycophenolate mofetil (CellCept) in patients with autoimmune hepatitis


P.O.Box 2925(59) College of Medicine, King Saud University , Riyadh 11461, Saudi Arabia

Correspondence Address:
Ayman A Abdo
P.O.Box 2925(59) College of Medicine, King Saud University , Riyadh 11461
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 19858585

Rights and PermissionsRights and Permissions

Autoimmune hepatitis (AIH) is a chronic inflammatory disease of the liver of unknown cause. Typically, immune suppressive therapy is used initially for treatment, either in the form of steroids or Azathioprime. In a small proportion of patients, steroids resistance or steroid intolerance develops. When patients are unresponsive to steroids, or develop severe significant side effects to their use, alternative treatments must be used. Mycophenolate mofetil (Cellcept) is a potent immune suppressive medication that is used in a wide variety of autoimmune diseases as well as post solid organ transplantation. Data is emerging to suggest that this medication may be used in selected patients with steroid resistance or steroid intolerance. This data is summarized in this review.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed6250    
    Printed173    
    Emailed2    
    PDF Downloaded446    
    Comments [Add]    

Recommend this journal